Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,572 | 325,286 | 112,000 | 117,311 | 207,075 |
| Marketable Securities | 136,796 | 153,767 | 194,337 | 186,328 | 134,255 |
| Receivables | 81,917 | 82,287 | 95,196 | 71,858 | 65,568 |
| TOTAL | $357,622 | $575,719 | $417,750 | $395,444 | $425,508 |
| Non-Current Assets | |||||
| PPE Net | 347,450 | 318,498 | 292,329 | 274,621 | 259,676 |
| Investments And Advances | 370,053 | 37,956 | 70,465 | 108,278 | 47,080 |
| Other Non-Current Assets | 14,307 | 10,260 | 10,097 | 8,813 | 8,938 |
| TOTAL | $731,810 | $366,714 | $372,891 | $391,712 | $315,694 |
| Total Assets | $1,089,432 | $942,433 | $790,641 | $787,156 | $741,202 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 53,658 | 74,976 | 58,256 | 53,905 | 49,031 |
| TOTAL | $109,056 | $133,833 | $119,571 | $104,093 | $93,575 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 54,723 | 58,223 | 60,867 | 49,753 | 44,544 |
| aiOther Non-Current Liabilities | 7,350 | 5,289 | 4,318 | 4,140 | 3,959 |
| TOTAL | $452,561 | $460,536 | $299,854 | $296,792 | $250,865 |
| Total Liabilities | $561,617 | $594,369 | $419,425 | $400,885 | $344,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,959 | 82,293 | 82,113 | 81,913 | 81,653 |
| Common Shares | 89 | 82 | 82 | 82 | 79 |
| Retained earnings | -1,045,563 | -1,030,966 | -997,091 | -971,617 | -941,095 |
| Other shareholders' equity | -2,491 | -175 | -306 | 717 | 1,046 |
| TOTAL | $527,815 | $348,064 | $371,216 | $386,271 | $396,762 |
| Total Liabilities And Equity | $1,089,432 | $942,433 | $790,641 | $787,156 | $741,202 |